Vernal Biosciences

Contract development and manufacturing organization (CDMO) · Colchester, Vermont, United States

Vernal Biosciences is a contract development and manufacturing organization (CDMO) headquartered in Colchester, Vermont, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $41 million sold in a notice filed in 2023.

www.vernal.bioProfile compiled from public records. Is this your company? Request a correction or update

Vernal Biosciences at a glance

Typecontract development and manufacturing organization (CDMO)
HeadquartersColchester, Vermont, United States
Earliest incorporation on record2020
SEC CIK1861147

What does Vernal Biosciences do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $41 million sold (2023).

Vernal Biosciences on the BioBridgeX marketplace

CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Plasmid DNA Manufacturing

Services

mRNA / RNA ManufacturingLNP / Delivery FormulationPlasmid DNA ManufacturingProcess DevelopmentAnalytical DevelopmentQC & Release Testing

Therapeutic areas

OncologyInfectious DiseaseRare / Orphan Disease

Modalities

mRNA / saRNAPlasmid DNAVaccineGene Therapy (AAV / Viral Vector)
Compare quotes

Unclaimed listing. Claim this profile

Frequently asked questions about Vernal Biosciences

Where is Vernal Biosciences headquartered?

Vernal Biosciences is headquartered in Colchester, Vermont, United States.

What does Vernal Biosciences do?

Vernal Biosciences is a contract development and manufacturing organization (CDMO).

When was Vernal Biosciences founded?

The earliest incorporation on record for Vernal Biosciences is in 2020, according to public company registers.

Similar companies

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.